30043200.74 |
Single preparation containing 7α-Hydroxytestosterone,and their derivatives and structuralanalogues,put up in measured doses |
kilogram/- |
30% |
L |
|
-- |
30043200.75 |
Single preparation containing 7β-Hydroxytestosterone,and their derivatives and structuralanalogues,not containing antibiotics,put up in measured doses |
kilogram/- |
30% |
L |
|
Compare-30043200.74 |
30043200.76 |
Single preparation containing 7-Hydroxytestosterone,and their derivatives and structuralanalogues,not containing antibiotics,put up in measured doses |
kilogram/- |
30% |
L |
|
Compare-30043200.75 |
30043200.77 |
Single preparation containing etiocholanolone,and their derivatives and structuralanalogues,not containing antibiotics,put up in measured doses |
kilogram/- |
30% |
L |
|
Compare-30043200.76 |
30043200.78 |
A single dose of a dose of 1,4-androstenedione (andros-1,4-diene-3,17-dione) including its derivatives and structural analogs,free of antibiotics,including retail packaging |
kilogram/- |
30% |
L |
|
Compare-30043200.77 |
30043200.99 |
Other medicines containing other corticosteroids (including their derivatives and structural analogues,no antibiotics,including retail packaging),the bottom tax number generated by the separation of anticancer drugs |
kilogram/- |
30% |
Q |
|
Compare-30043200.78 |
30043900.11 |
Single preparation containing clenbuterol,put up in measured doses,packings for retail sale |
kilogram/- |
30% |
L |
|
Compare-30043200.99 |
30043900.21 |
has been prepared as a monotherapy (anticancer drug) containing dosages of goserelin acetate,leuprorelin acetate,triptorelin acetate,or triptorelin dihydroxynaphthalate |
kilogram/- |
30% |
L |
|
Compare-30043900.11 |
30043900.22 |
Single preparation containing growth hormone,in measured doses,packings for retail sale |
kilogram/- |
30% |
L |
|
Compare-30043900.21 |
30043900.25 |
Single preparation containing gonadotrophins,in measured doses,packings for retail sale |
kilogram/- |
30% |
L |
|
Compare-30043900.22 |
30043900.26 |
Single preparation containing corticotrophins,in measured doses,packings for retail sale |
kilogram/- |
30% |
L |
|
Compare-30043900.25 |
30043900.27 |
Monomer preparation dose containing leuprolide |
kilogram/- |
30% |
L |
|
Compare-30043900.26 |
30043900.28 |
Monomer preparation containing dose of DHEA therapy |
kilogram/- |
30% |
L |
|
Compare-30043900.27 |
30043900.29 |
Single preparation containing clenbuterol,put up in measured doses,packings for retail sale |
kilogram/- |
30% |
L |
|
Compare-30043900.28 |
30043900.40 |
Single preparation containing clenbuterol,put up in measured doses,packings for retail sale |
kilogram/- |
30% |
R |
|
Compare-30043900.29 |
30043900.91 |
Anti-anti-cancer drug preparation (excluding cancer adjuvant treatment drugs) |
kilogram/- |
30% |
Q |
|
Compare-30043900.40 |
30043900.92 |
Other prescriptions containing follistatin |
kilogram/- |
30% |
L |
|
Compare-30043900.91 |
30043900.93 |
Other doses containing a single formulation of marsulelin |
kilogram/- |
30% |
L |
|
Compare-30043900.92 |
30043900.95 |
Rare disease drug preparations. |
kilogram/- |
30% |
Q |
|
Compare-30043900.93 |
30043900.99 |
Other medicines containing hormones or heading 2937 products (excluding antibiotics,including retail packaging) |
kilogram/- |
30% |
Q |
|
Compare-30043900.95 |